Bone biomarkers and overall survival (OS) in men with advanced hormone-sensitive prostate cancer (HSPC): Results from SWOG S1216, a phase III trial of ADT +/- orteronel. a PSA progression is defined ...

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma Factors correlated with ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

Many symptoms associated with prostate cancer, like frequent urination or difficulty peeing, may be caused by less-serious concerns. Learn more.

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

A Prostate-Specific Antigen (PSA) test is a procedure formed on men to detect prostate cancer. It is considered an effective means of cancer screening and can be used to monitor the effectiveness of ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

Offering prostate cancer tests only to men with a confirmed genetic marker for it leaves black men at greater risk, a man ...

In tandem with September’s Prostate Cancer Awareness Month, Cleveland Diagnostics is kicking off a campaign to boost awareness of and education around screening tests for the disease. The flagship ...

UCLA researchers found that routine PSMA PET/CT scans could help doctors select treatment approaches for the best long-term outcomes in patients with recurring prostate cancer after surgical removal ...